Sponsor or institution
Clinical trials and research at Samsung Medical Center
As of November 12, 2026, Find a Trial lists 115 clinical trials run by Samsung Medical Center that are recruiting, in South Korea. 3 were first registered in the last 30 days. By phase: Phase 2 (24), Phase 4 (9), Phase 3 (5), Phase 1/2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 115Clinical trials
- 3New in 30 days
- 1Country
Newest trials
All recruiting trials (115)
-
Neoadjuvant trastuzumab, durvalumab, and FLOT for HER2-positive gastric or GEJ cancer
This study tests a pre-surgery treatment combining trastuzumab, durvalumab, and FLOT for patients with HER2-positive locally advanced gastric or gastroesophageal junction cancer to see how many achieve complete tumor disappearance.
-
Integrated genomic and clinical database for cancer biomarker discovery
Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.
-
PULSAR radiotherapy plus immunotherapy for high-risk advanced liver cancer
This study tests whether adding PULSAR radiotherapy to standard immunotherapy helps adults with high‑risk advanced liver cancer live longer without their cancer progressing.
-
Wearable eye tracking during bimanual tasks in children with cerebral palsy
This study tests whether wearable eye-tracking glasses can reliably record eye movements while children with CP and typically developing peers perform two-handed tasks.
-
Breast cancer after breast-conserving surgery without sentinel node biopsy: radiotherapy outcomes
This study tests how well radiotherapy works for early-stage breast cancer patients who had breast-conserving surgery without removing a sentinel lymph node.
-
3D Echocardiography to See How CIEDs May Worsen Tricuspid Regurgitation
This study tests whether different CIEDs (leadless pacemakers, LBBaP, and conventional pacemakers) differ in causing worsening tricuspid regurgitation, using 3D heart imaging.
-
Thoracoscopic vs Catheter Ablation as the First Rhythm Control in Atrial Fibrillation with a Large Left Atrium
This trial tests whether thoracoscopic surgical ablation is better at keeping atrial fibrillation under control than catheter ablation in people with persistent AF and a large left atrium who have not had an ablation before.
-
LLM-based refreshers vs video refreshers after PALS training
We test whether an AI-powered refresher or a video refresher better helps healthcare professionals keep PALS knowledge and skills six months after simulation training.
-
SGLT2 inhibitor after cardioversion to help keep sinus rhythm in AF with HFpEF
A large study will test whether starting an SGLT2 inhibitor after successful electrical cardioversion helps people with persistent atrial fibrillation and HFpEF stay in normal heart rhythm for at least a month.
-
Lower starting lazertinib dose with magnesium to prevent nerve side effects in EGFR-mutant NSCLC
This study tests whether starting lazertinib at a lower dose plus magnesium helps prevent peripheral neuropathy in newly diagnosed EGFR-mutant NSCLC patients.
-
Digital Therapeutics for Social Cognition in Schizophrenia Spectrum Disorder
A smartphone-based digital therapy called AffectUs is being tested to see if it can help people with schizophrenia or schizoaffective disorder improve social cognition, alongside their usual treatment.
-
Edoxaban vs. Apixaban in AF with CAD: Net Benefit
This trial tests whether edoxaban-based therapy provides a similar or better overall benefit than apixaban-based therapy for stroke prevention and major bleeding in adults with atrial fibrillation and coronary artery disease.
-
Personalized AF ablation: anatomy-based vs Emphasize map-guided substrate ablation
We’re testing two catheter ablation approaches for persistent atrial fibrillation to see which one leads to fewer or shorter episodes of abnormal heart rhythms over a year.
-
Belvarafenib in BRAF-altered brain tumors
This Phase 2 study tests Belvarafenib daily to see if it can help people with BRAF-altered primary or metastatic brain tumors.
-
Personalized PEEP strategy for intrinsic PEEP during one-lung ventilation
The study tests three PEEP approaches (0, 5, and a personalized level based on intrinsic PEEP) to see which best supports patients with intrinsic PEEP during lung surgery.
-
How often do kids in the PICU get rehab services in Korea
This study tests how often acute rehabilitation practices are used for children in Korean PICUs.
-
Personalized ultrafractionated radiation plus immunotherapy for unresectable stomach cancer
This study tests, in patients with unresectable locally advanced stomach cancer who have not progressed after initial therapy, whether adding PULSAR radiation to ongoing systemic treatment improves control of the tumor.
-
Early rhythm control in atrial fibrillation with tricuspid regurgitation
This study tests whether starting rhythm control early in people with atrial fibrillation and tricuspid regurgitation can improve outcomes compared with usual care.
-
See if Continuous Glucose Monitoring can help diagnose dumping syndrome after esophagectomy
Researchers are testing whether a wearable continuous glucose monitor can help spot dumping syndrome in people who had esophageal cancer surgery with a stomach tube reconstruction.
-
Personalized pacemaker rate setting to improve symptoms in heart failure with bradycardia
Researchers will try adjusting the pacemaker lower rate to a personalized, hemodynamically optimized heart rate to see if it reduces symptoms in people with heart failure who need a pacemaker.
-
Using CT scans to predict benefit from chemoimmunotherapy before lung cancer surgery
This project will test whether CT scan features can predict how adults with resectable non-small cell lung cancer respond to chemoimmunotherapy given before surgery.
-
Short-course versus moderate-course salvage radiation for rising PSA after prostate removal
This trial will test whether a very short course of salvage radiotherapy (31 Gy in 5 treatments over two weeks) works as well and has acceptable side effects as a moderate course (60 Gy in 24 treatments over 5–6 weeks) for men with a rising PSA after prostatectomy.
-
Routine versus provisional distal perfusion catheter placement during mechanical circulatory support
This study tests whether placing a distal perfusion catheter routinely or only provisionally improves limb outcomes in patients needing femoral artery support for mechanical circulatory support.
-
Routine use of Potassium Competitive Acid Blocker vs guideline GI protection in AMI with PCI
This trial tests whether giving a potassium competitive acid blocker regularly after AMI with PCI and DAPT helps more than following standard GI protection guidelines.
-
Korean cohort for monitoring high-grade upper tract urothelial carcinoma
This project will test whether blood-based ctDNA taken before chemotherapy and again after surgery can help monitor recurrence risk in Korean adults with high-grade, non-metastatic upper tract urothelial carcinoma who are planned for neoadjuvant chemotherapy and radical nephroureterectomy.
-
Early rhythm control treatment for subclinical atrial fibrillation
This study tests whether starting rhythm-control treatments early can reduce abnormal heart rhythm episodes in people whose subclinical atrial fibrillation was found by implantable heart devices.
-
Short-course (hypofractionated) IMRT with weekly cisplatin for locally advanced cervical cancer
This trial tests whether a shorter course of targeted pelvic radiation (hypofractionated IMRT) plus weekly cisplatin works and is safe for people with locally advanced cervical cancer.
-
Long-term registry for Korean patients with heart and brain vascular disease
This project will collect past and ongoing medical records to see if combining them improves prediction of future health outcomes for Korean patients with heart and blood vessel diseases.
-
Adaptive pulse radiotherapy added to immunotherapy for advanced solid tumors
This trial will test whether adding adaptive pulse radiotherapy to immune checkpoint inhibitors helps people with advanced solid tumors respond better and live longer.
-
AI system to analyze breathing in children with respiratory distress
This project will test an AI tool that uses clinical information and video of breathing to analyze respiratory patterns in children aged 0–12 who come to emergency departments with breathing problems.
-
Bachmann bundle versus right atrial appendage pacing in sick sinus syndrome
This research tests whether pacing the Bachmann bundle instead of the right atrial appendage reduces atrial structural and functional damage in people with sick sinus syndrome who are getting a permanent pacemaker.
-
AI-driven Medipixel fractional flow reserve to guide PCI
This test checks whether an AI-based, angiography-derived Medipixel FFR method can guide PCI as safely and effectively as standard invasive pressure-wire FFR in adults with coronary artery disease.
-
PULSAR personalized ultrafractionated adaptive proton radiotherapy combined with systemic therapy for pancreatic cancer
This trial will test whether personalized PULSAR proton radiotherapy given after initial chemotherapy can improve local control for people with borderline resectable, locally advanced, or limited metastatic pancreatic cancer.
-
Force feedback on the da Vinci 5 robot to improve learning and safety in radical prostatectomy
This trial will test whether haptic (force) feedback on the da Vinci 5 robot helps surgeons learn and perform robot-assisted radical prostatectomy more safely in men with localized prostate cancer.
-
Cisplatin chemotherapy followed by maintenance avelumab for upper tract urothelial carcinoma
This trial will try maintenance avelumab after adjuvant cisplatin chemotherapy to see if it reduces recurrence in adults with high-risk, surgically removed upper tract urothelial carcinoma who are disease‑free after chemo.
-
Multi-omics profiling to optimize immunotherapy for advanced head and neck cancer
This project will test whether detailed tumor and blood profiling before and after first-line chemotherapy plus immunotherapy can help identify which people with recurrent or metastatic head and neck squamous cell carcinoma benefit.
-
HOPE: Using tumor omics to guide precision medicine for head and neck cancer
This project will try using detailed genetic and molecular testing of tumors from adults with head and neck cancer to see if it can help guide more personalized treatment decisions.
-
FDG PET-CT to track treatment response in advanced breast cancer
This study will test whether FDG PET-CT scans better track treatment response than standard CT (± bone scan) in people starting first-line therapy for advanced breast cancer.
-
Comparing argon plasma coagulation and endoscopic mucosal resection for small gastric adenomas
This trial will test whether argon plasma coagulation or endoscopic mucosal resection works better to treat small (≤1 cm) gastric adenomas with low-grade dysplasia.
-
COPM-guided goal setting for children in the PICU
This will try using the COPM tool with therapists and caregivers to set personalized rehabilitation goals for children aged 1–18 who are admitted to the PICU.
-
Stereotactic body radiotherapy (SABR) for limited metastases
This program tries stereotactic body radiotherapy (SABR) in people with up to five oligometastatic or oligoprogressive cancer lesions to see if it controls disease better, affects symptoms and side effects, and changes ctDNA in the blood.
-
Using a potassium‑competitive acid blocker after PCI to protect the stomach.
We will see if giving a potassium‑competitive acid blocker instead of a proton pump inhibitor helps prevent stomach bleeding in people who had PCI and are taking dual antiplatelet medicines.
-
Predicting drops in cardiac output during general anesthesia using breathing-monitor data
This will test whether an AI algorithm can use capnography (breathing monitor) data to predict significant drops in cardiac output in adults having elective surgery with general anesthesia.
-
Tracking blood markers in aggressive Hodgkin and non-Hodgkin lymphoma
This project will try to use blood tests (serum and cell-free DNA) to track treatment response and outcomes for adults with aggressive Hodgkin or non-Hodgkin lymphoma.
-
Personalized 4-week nutrition and activity program for people after esophageal cancer surgery
This 4-week program will try personalized nutrition plans, customized care foods, step-tracking, and weekly phone counseling to see if they help people who had surgery for esophageal cancer feel better and eat more comfortably.
-
Optimal side-branch stenting strategy for complex coronary bifurcation using drug-coated balloons
This study tests whether starting with two stents or using a drug-coated balloon (DCB)-based hybrid approach works better for adults having PCI for complex coronary bifurcation lesions with an important side branch.
-
Coronary CT angiography versus standard follow-up after stent placement for high-risk patients
This trial will test whether using coronary CT angiography instead of usual follow-up care helps people at high risk after stent placement stay healthier.
-
Validation of a non-invasive device to predict low blood pressure during surgery
This study is testing a new device that can help doctors predict low blood pressure during surgery to keep patients safer.
-
Comparing bronchial blockers and double-lumen tubes in esophagectomy
This study is testing if using a bronchial blocker instead of a double-lumen tube during esophagus surgery can help prevent voice problems in adults who need lymph node removal near their vocal cords.
-
Home-based upper limb rehabilitation with the Neofect Smart Board for late subacute and chronic brain disorder patients
This trial will test whether home-based arm exercises using the Neofect Smart Board help adults (19–85) with lasting arm weakness from stroke, traumatic brain injury, or brain tumor more than conventional home occupational therapy.
-
Home-based smart glove therapy to improve arm movement after brain injury
This test tries the Neofect smart glove at home to see if it improves arm function more than usual home occupational therapy for adults (19–85) with late subacute or chronic arm weakness from brain injury.
-
Tarlatamab with carboplatin/etoposide and atezolizumab for EGFR‑mutant lung adenocarcinoma that changed into small cell lung cancer
This trial tests whether adding tarlatamab to standard platinum‑etoposide chemotherapy and atezolizumab helps patients whose EGFR‑mutant lung adenocarcinoma has transformed into small cell lung cancer.
-
Comparing drug-coated balloons and drug-eluting stents for patients with high bleeding risk and chronic coronary syndrome
This study is testing whether using drug-coated balloons instead of drug-eluting stents can help patients with chronic coronary syndrome who are at high risk for bleeding, while also looking at how long they need to take blood-thinning medicine after the procedure.
-
Personalized digital healthcare for managing side effects in breast cancer survivors
This study is testing a new digital health program to help breast cancer survivors manage side effects from their treatments using a mobile app and smartwatch.
-
Early versus standard continuous dialysis for adults with cardiogenic shock on VA‑ECMO
We will test whether starting continuous dialysis earlier helps adults with cardiogenic shock and moderate-to-severe acute kidney injury who are on veno-arterial ECMO, compared with the usual timing.
-
Perioperative HER2-targeted therapy plus chemotherapy for locally advanced unresectable stomach or gastroesophageal junction cancer
This Phase 2 trial tests giving trastuzumab deruxtecan with capecitabine (and rilvegostomig) before and after surgery for adults with HER2-positive, locally advanced unresectable stomach or GEJ cancer to try to shrink tumors so they can be removed and lower the chance of recurrence.
-
Preventing neutropenia from sacituzumab govitecan in metastatic triple-negative breast cancer
This trial tests sacituzumab govitecan given with pegfilgrastim to see if it prevents low white blood cell counts in people with metastatic triple-negative breast cancer who have had one or two prior chemotherapy regimens.
-
Using Selinexor with ICE chemotherapy for B-cell lymphoma with CNS involvement
This study is testing if adding Selinexor to standard chemotherapy can help people with B-cell lymphoma that has spread to the brain feel better when other treatments haven't worked.
-
Comparing two radiation therapy methods for high-risk cervical cancer after surgery
This study is testing two different radiation therapy methods to see which one works better for women with high-risk cervical cancer after surgery.
-
Developing an AI model for personalized medicine in acute respiratory failure
This study is trying to create a new AI tool that helps doctors understand different types of patients with acute respiratory failure in the ICU and how they might respond to treatment.
-
Comparing systemic treatment alone to systemic treatment with added radiotherapy for kidney cancer with few metastases
This study is testing if adding targeted radiation therapy to regular treatment can help people with kidney cancer that has spread a little to live longer without their cancer getting worse.
-
Evaluating safety of increased radiation doses for prostate cancer treatment
This study is testing whether giving higher doses of radiation safely helps men with low-to-intermediate risk prostate cancer while keeping side effects, like rectal bleeding, to a minimum.
-
Safety of increased radiation doses with hormone therapy for high-risk prostate cancer
This study is testing if giving higher doses of radiation along with hormone therapy can help men with high-risk prostate cancer without causing too many side effects.
-
Patritumab deruxtecan for solid tumors with NRG1 fusion
This study is testing a new treatment called patritumab deruxtecan to see if it helps people with solid tumors that have a specific genetic change known as an NRG1 fusion.
-
Personalized rTMS therapy to improve walking in Parkinson's patients
This study is testing whether personalized brain stimulation can help improve walking in people with Parkinson's disease better than standard treatments.
-
Understanding how breast cancer spreads to the brain
This study is trying to understand how breast cancer spreads to the brain in patients who have had surgery for brain tumors, to help find better treatments.
-
Anesthesia type and lung cancer recurrence after curative surgery
This trial will test whether using propofol-based total intravenous anesthesia (TIVA) instead of inhaled volatile anesthetics lowers the chance of cancer coming back after curative lung surgery in adults with non-small cell lung cancer.
-
Understanding how trastuzumab deruxtecan works in HER2 positive breast cancer
This study is trying to understand why some people with HER2 positive breast cancer don’t respond to the treatment trastuzumab deruxtecan, to help improve future treatment options.
-
Comparing antiplatelet therapies after carotid artery stenting in high bleeding risk patients
This study is testing whether a combination of two blood-thinning medications is safer and more effective than just one for patients with carotid artery disease who have a high risk of bleeding after getting a stent.
-
Personalized rTMS therapy to improve upper limb function in stroke patients
This study is testing if personalized brain stimulation can help improve arm movement in stroke patients by tailoring the treatment to their specific needs.
-
Examining LAG3 Expression in Triple Negative Breast Cancer
This study is testing how a protein called LAG-3 affects treatment outcomes in patients with triple negative breast cancer who are receiving chemotherapy along with an immune therapy.
-
Evaluating coronary microvascular dysfunction in heart failure patients
This study is trying to see if problems with tiny blood vessels in the heart affect how well people with heart failure can improve their heart function after treatment.
-
Early diagnosis of lung cancer in Korean women
This study is testing a new way to find lung cancer early in Korean women aged 45-74 who have never smoked and have a family history of the disease.
-
Adding tepotinib to lazertinib for EGFR‑mutant metastatic lung cancer with MET overexpression or amplification after progression on lazertinib
This trial tests whether adding the MET blocker tepotinib to lazertinib helps people with EGFR‑mutant metastatic non‑small cell lung cancer whose tumors show MET overexpression or amplification and who have progressed on lazertinib.
-
New treatment for children with standard risk acute lymphoblastic leukemia
This study is testing a new treatment plan for children with standard risk acute lymphoblastic leukemia to see if using genetic testing can help improve their chances of recovery.
-
Combination of Trastuzumab Deruxtecan and Afatinib for HER2-low Advanced Gastric Cancer
This study is testing a new combination of two drugs, Trastuzumab Deruxtecan and Afatinib, to see if it can help people with HER2-low advanced gastric cancer who don’t have many treatment choices.
-
Haploidentical stem cell transplantation with early ATG and low-dose cyclophosphamide
This study is testing if giving a special medication and a lower dose of chemotherapy right after a stem cell transplant can help patients who don't have a matched donor recover better.
-
Evaluating outcomes and side effects of salvage treatment for recurrent breast cancer
This study is testing how well salvage treatments work and what side effects they cause in women with recurring breast cancer that hasn't spread to other parts of the body.
-
Observing outcomes of high-precision radiotherapy in metastatic breast cancer
This study looks at how well high-precision radiation treatments work for people with metastatic breast cancer who have already had or are about to receive advanced radiation therapies.
-
Radiation therapy tailored to tumor biology for advanced breast cancer
This study is testing if adjusting radiation therapy based on how well tumors respond to earlier chemotherapy can help people with advanced breast cancer live longer and feel better after treatment.
-
Analyzing radiation therapy outcomes in HER2 positive breast cancer
This study looks at how well radiation therapy works for women with HER2 positive breast cancer after they have had surgery, to see if it helps prevent cancer from coming back and to track any side effects over seven years.
-
Radiation therapy for endometrial cancer after surgery
This study tests a new type of radiation therapy for women with stage III endometrial cancer after surgery to see if it helps them stay cancer-free as well as traditional treatments.
-
Aggressive cholesterol-lowering treatment for asymptomatic patients with coronary calcification
This study is testing whether a strong cholesterol-lowering treatment can help people over 40 with heart calcification avoid heart problems, even if they don't have any symptoms.
-
Comparing revascularization and medical treatment for heart failure with reduced ejection fraction
This study is testing if opening blocked arteries with a procedure helps people with heart failure feel better compared to just taking medication.
-
Comparing IVUS and FFR for treating artery lesions in heart attack patients
This study is testing whether using ultrasound or a different method to guide treatment for blocked arteries helps heart attack patients with multiple affected vessels get better results after their initial procedure.
-
Comparing invasive and non-invasive diagnostic approaches for coronary artery disease
This study is testing whether invasive heart tests or non-invasive tests are better for helping patients with certain types of coronary artery disease after they've had a CT scan.
-
Comparing routine and as-needed stress testing for patients with high coronary calcium
This study is testing whether regular stress tests are better than only doing them when needed for people who have a high coronary calcium score but no heart disease symptoms.
-
Registry for patients undergoing percutaneous coronary intervention
This study is collecting information from patients with coronary artery disease who have had or will have a heart procedure to see how they do over time and what factors might affect their recovery.
-
Combination treatment for advanced gastric cancer with MET amplification
This study is testing a new combination treatment of durvalumab and savolitinib for patients with advanced gastric cancer who have not responded to previous chemotherapy and have a specific genetic change called MET amplification.
-
Validation of a new laparoscopic instrument for colorectal cancer surgery
This study is testing a new surgical tool for colorectal cancer surgery to see if it is safe and works well compared to robotic surgery techniques for patients with rectal and rectosigmoid junction cancers.
-
Using osimertinib to prevent progression of lung cancer nodules after surgery
This study is testing if the drug osimertinib can help prevent lung cancer nodules from getting worse in patients who have had surgery for their cancer.
-
Comparing revascularization strategies for heart attack patients with cardiogenic shock
This study is testing whether treating multiple blocked heart arteries right away helps heart attack patients in shock feel better compared to just fixing the main blockage.
-
Evaluating exercise testing for diagnosing heart issues in patients with exertional dyspnea
This study is testing a new way to diagnose heart problems in people who get short of breath during exercise by using special tests that look at how the heart and lungs work together.
-
Combining Tislelizumab with Radiotherapy for Newly Diagnosed NK/T-cell Lymphoma
This study is testing if combining a new immune therapy called Tislelizumab with radiotherapy can help people newly diagnosed with NK/T-cell lymphoma feel better and have fewer side effects than standard treatments.
-
Hypofractionated radiation therapy with chemotherapy for bladder cancer
This study is testing a new way to treat muscle-invasive bladder cancer using a combination of radiation and chemotherapy to see if it helps preserve the bladder while reducing side effects and treatment time.
-
Evaluation of a new biodegradable polymer coronary stent for heart disease
This study is testing a new type of heart stent made from biodegradable material to see if it works better and is safer for people with coronary artery disease compared to a traditional stent.
-
Combining Aspirin and Hydroxychloroquine for High-Risk Pregnancies to Prevent Preeclampsia
This study is testing if taking a combination of hydroxychloroquine and aspirin can help pregnant women at high risk for preeclampsia have healthier pregnancies compared to just taking aspirin alone.
-
Comparing two treatment regimens for elderly patients with mantle cell lymphoma
This study is testing if an alternating treatment plan for mantle cell lymphoma can help older patients feel better compared to the standard treatment they usually receive.
-
Combination treatment for nodal T-cell lymphoma with T-follicular helper phenotype
This study is testing a new combination of a drug called azacitidine with standard chemotherapy to see if it helps people with a specific type of nodal T-cell lymphoma feel better and have better results.
-
Evaluating the weaning process from mechanical ventilation in medical patients
This study looks at how to safely help adults in the ICU stop using mechanical ventilation by checking their breathing and health to see what works best.
-
Peri-procedure SGLT-2 inhibitor to reduce heart attack damage and heart remodeling
This trial will test whether taking an SGLT‑2 diabetes medicine around the time of PCI can shrink the heart attack scar and limit heart remodeling in adults with acute myocardial infarction who are at high risk for heart failure.
-
Treatment for premenopausal women with metastatic breast cancer
This study is testing whether a new treatment combining talazoparib with atezolizumab works better than talazoparib alone for premenopausal women with a specific type of metastatic breast cancer.
-
Evaluating the effects of stopping beta-blockers after heart attack
This study is testing whether stopping beta-blocker medication after a heart attack is just as good for recovery as continuing to take it for people who don't have heart failure.
-
Genetic sequencing for people with early gastric cancer or gastric adenoma
This project will test whether genetic sequencing of tumor tissue, blood, and gastric fluids can find markers to diagnose early gastric cancer and predict recurrence in people with early gastric cancer or gastric adenoma.
-
Lenalidomide and Rituximab for Patients with Primary CNS Lymphoma Who Can't Have Transplants
This study is testing if a combination of two medications, lenalidomide and rituximab, can help older patients or those in poor health with primary CNS lymphoma who can't have a stem cell transplant stay healthy longer after their initial treatment.
-
Osimertinib to slow growth of remaining ground-glass nodules after lung cancer surgery
This will try daily oral osimertinib (80 mg) to slow or stop growth of persistent ground-glass nodules in adults who had surgery for stage I lung adenocarcinoma with an L858R or exon 19 EGFR mutation.
-
Comparing two treatments for patients with complex coronary lesions undergoing PCI
This study is testing whether using aspirin with prasugrel or aspirin with clopidogrel is better for people with complex heart issues who are having a procedure to open blocked arteries.
-
Using cell-free DNA to detect recurrence in early non-small cell lung cancer
This study is testing if checking for tumor DNA in the blood can help find out sooner if non-small cell lung cancer comes back after surgery.
-
Examining the link between skinfold thickness and survival in certain cancers
This study tests if measuring skinfold thickness can help predict how long people with pancreatic, cholangiocarcinoma, and gallbladder cancers might live, especially those struggling with weight loss.
-
Identifying biomarkers for lung cancer immunotherapy
This study is trying to find specific markers in lung cancer patients' samples to see if they can predict how well immunotherapy treatments will work for them.
-
Cohort study for patients with aggressive lymphoma
This study looks at patients with aggressive lymphoma to see how well standard treatments work and how the disease changes over time.
-
Observational study on adult hemophagocytic lymphohistiocytosis
This study is looking at adults with hemophagocytic lymphohistiocytosis to learn more about their symptoms and how they respond to treatments like immunosuppressive therapy or chemotherapy.
-
Evaluating microvascular function in heart transplant patients
This study is testing new ways to check blood flow in heart transplant patients to see if it can help spot early signs of heart problems that could lead to serious health issues.
-
Assessing microvascular function in patients with cardiac amyloidosis
This study is testing how well the tiny blood vessels in the hearts of people with cardiac amyloidosis are working to see if it can help understand their condition better.
-
Molecular screening for relapsed small cell lung cancer patients
This study is testing a way to analyze the DNA from tissue and blood samples of patients with relapsed small cell lung cancer to see if it can help identify who might benefit from new treatments.
Quick answers
How many clinical trials run by Samsung Medical Center are recruiting right now?
115, as of November 12, 2026. 3 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in South Korea. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 24, Phase 4: 9, Phase 3: 5, Phase 1/2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.